-
2024-517147-31-00
9
2025-05-23
Tumours, Gynecological
-
2024-517812-31-00
6
2025-05-21
Haemophilia A
-
2023-509627-40-01
5
2025-05-15
subarachnoid hemorrhage
-
2023-508634-34-00
4
2025-05-14
co-infected with the HIV-1 and HBV viruses
-
2024-516615-25-00
1
2025-05-14
hepatocellular carcinoma (HCC)
-
2024-519822-18-00
10
2025-05-14
Narcolepsy Type 1, Type 2 and Idiopathic Hypersomnia
-
2024-516605-23-00
5
2025-05-12
relapsed/refractory nodal T cell lymphoma with T follicular helper (TF
-
2024-515593-27-00
5
2025-05-08
relapsed or refractory mantle cell lymphoma (R/R MCL)
-
2024-515793-27-01
5
2025-04-30
HIV
-
2024-513054-30-00
5
2025-04-16
Moderately to Severely Active Crohn's Disease (CD)
-
2023-506601-19-00
6
2025-04-15
transplantation
-
2023-505789-27-00
4
2025-04-14
Relapsed or Refractory Non-Hodgkin Lymphoma
-
2024-516791-15-00
4
2025-04-08
Relapsed/Refractory Aggressive B-Cell Non-Hodgkin’s Lymphoma (NHL)
-
2024-512633-32-00
4
2025-04-07
Crohn's disease
-
2023-504550-35-00
5
2025-04-03
Atypical Hemolytic Uremic Syndrome (aHUS)
-
2023-504086-23-00
5
2025-03-27
Subjects with PBC with a non-optimal response to UDCA.
-
2024-514804-14-00
6
2025-03-26
Liver transplantation
-
2023-507937-14-00
7
2025-03-25
Metastatic Solid Tumor
-
2023-510079-74-00
5
2025-03-06
meniscal pain of degenerative origin
-
2024-515034-33-00
9
2025-03-05
Chronic Lymphocytic Leukaemia
-
2024-517419-62-00
4
2025-02-28
HER2 mutation
-
2024-515020-36-00
9
2025-02-24
Advanced Solid tumour
-
2024-516044-25-00
10
2025-02-13
Migraines with aura
-
2024-516306-28-00
10
2025-02-12
Autism with Spectrum Disorders and Moderate to Severe Intellectual Dis